BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 33638255)

  • 1. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis.
    Agnello L; Colletti T; Lo Sasso B; Vidali M; Spataro R; Gambino CM; Giglio RV; Piccoli T; Bivona G; La Bella V; Ciaccio M
    Eur J Neurol; 2021 Jun; 28(6):1868-1875. PubMed ID: 33638255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis.
    Klíčová K; Mareš J; Menšíková K; Kaiserová M; Friedecký D; Kaňovský P; Strnad M; Matěj R
    Eur J Med Res; 2024 Jan; 29(1):31. PubMed ID: 38184629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.
    Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N
    Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral Sclerosis.
    Cousins KAQ; Shaw LM; Shellikeri S; Dratch L; Rosario L; Elman LB; Quinn C; Amado DA; Wolk DA; Tropea TF; Chen-Plotkin A; Irwin DJ; Grossman M; Lee EB; Trojanowski JQ; McMillan CT
    Ann Neurol; 2022 Nov; 92(5):807-818. PubMed ID: 35877814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis.
    Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N
    Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis.
    Nukui T; Matsui A; Niimi H; Sugimoto T; Hayashi T; Dougu N; Konishi H; Yamamoto M; Anada R; Matsuda N; Kitajima I; Nakatsuji Y
    BMC Neurol; 2021 Jun; 21(1):255. PubMed ID: 34193068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis.
    Kläppe U; Sennfält S; Lovik A; Finn A; Bofaisal U; Zetterberg H; Blennow K; Piehl F; Kmezic I; Press R; Samuelsson K; Månberg A; Fang F; Ingre C
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):150-161. PubMed ID: 37789557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF p-tau as a potential cognition impairment biomarker in ALS.
    Gong Z; Gao L; Lu Y; Wang Z
    Front Neurol; 2022; 13():991143. PubMed ID: 36388201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis.
    Yang J; Liu T; Zhang L; Li X; Du FP; Liu Q; Dong H; Liu Y
    Front Neurol; 2023; 14():1289467. PubMed ID: 38187158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post-onset ΔFS for study design and medical practice.
    Ludolph AC; Corcia P; Desnuelle C; Heiman-Patterson T; Mora JS; Mansfield CD; Couratier P
    Muscle Nerve; 2024 Jul; 70(1):36-41. PubMed ID: 38712849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis.
    Dellar ER; Vendrell I; Talbot K; Kessler BM; Fischer R; Turner MR; Thompson AG
    J Neurochem; 2024 Feb; 168(2):115-127. PubMed ID: 38087504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study.
    Martinelli I; Zucchi E; Simonini C; Gianferrari G; Bedin R; Biral C; Ghezzi A; Fini N; Carra S; Mandrioli J
    Eur J Neurol; 2024 Jan; 31(1):e16054. PubMed ID: 37679868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.
    Yang J; Xin C; Huo J; Li X; Dong H; Liu Q; Li R; Liu Y
    Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid biomarkers for amyotrophic lateral sclerosis: a review.
    Irwin KE; Sheth U; Wong PC; Gendron TF
    Mol Neurodegener; 2024 Jan; 19(1):9. PubMed ID: 38267984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis.
    Gentile F; Maranzano A; Verde F; Bettoni V; Colombo E; Doretti A; Olivero M; Scheveger F; Colombrita C; Bulgarelli I; Spinelli EG; Torresani E; Messina S; Maderna L; Agosta F; Morelli C; Filippi M; Silani V; Ticozzi N
    J Neurol; 2024 Feb; 271(2):794-803. PubMed ID: 37801095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis.
    Howe SL; Holdom CJ; McCombe PA; Henderson RD; Zigman JM; Ngo ST; Steyn FJ
    Eur J Neurol; 2024 Jan; 31(1):e16052. PubMed ID: 37658515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomic analysis of the cerebrospinal fluid from patients with amyotrophic lateral sclerosis based on tandem mass spectrometry technique].
    Su D; Zhang Y; Bi F; Xiao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):428-436. PubMed ID: 31068286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical factors and vascular endothelial growth factor as determinants of disease progression in Indian patients with amyotrophic lateral sclerosis.
    Thomas A; Garg D; Srivastava AK; Kumar A; Pandit AK; Vibha D; Vivekanandhan S; Shukla G; Prasad K
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):46-52. PubMed ID: 37710422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms.
    Kano O; Tanaka K; Kanno T; Iwasaki Y; Ikeda JE
    Sci Rep; 2018 Jan; 8(1):6. PubMed ID: 29311650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.